BBLG — BONE BIOLOGICS CORP
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying BBLG?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 1 tracked investors who changed their BBLG position last quarter, 0 bought and 1 sold (0% buy-side). Macro conditions are a headwind for this sector (Macro Tailwind 38/100 in a Expansion regime).
- +1 tracked investors reported holding BBLG at their latest filing
- −1 tracked investor reduced or exited last quarter (1 reduced, 0 sold out)
- −Current Expansion regime has historically been a headwind for this sector (Macro Tailwind 38/100)
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 11/22/2026.
About BONE BIOLOGICS CORP (BBLG)
BONE BIOLOGICS CORP (BBLG) appears in the most recent 13F filings of 1 tracked institutional investor. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $2M. Across recent filings, tracked investors recorded 1 new positions, 1 increased, 3 reduced, and 1 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in BBLG
How many top investors track BBLG
Only 1 tracked investor report this position.
BBLG Ownership Composition
How BONE BIOLOGICS CORP is held across tracked investor types, based on reported 13F positions.
- Multi-Strategy / Quant100.0%
Tracked investors currently reporting BBLG
- Ken GriffinSep 30, 2026Citadel AdvisorsShares17.9KValue$68K% Portfolio0.00%
Recent activity
- Reduced$68K(-32.18%)Nov 16, 2026
- New$1.8MNov 14, 2024
- Increased$556.5K(2.65%)May 15, 2025
- Reduced$535.1K(-0.01%)Aug 14, 2025
- Sold$0(-100.00%)Nov 14, 2025
- Reduced$396K(-11.27%)Aug 14, 2026
Frequently asked questions
- How many institutional investors hold BBLG?
- 1 tracked institutional investor disclosed a position in BBLG (BONE BIOLOGICS CORP) in their most recent 13F filing.
- Who is the largest institutional holder of BBLG?
- Ken Griffin, Citadel Advisors, holds the largest disclosed position in BBLG, valued at $2M.
- Did institutional ownership of BBLG increase or decrease?
- Across recent 13F filings, tracked investors recorded 1 new positions, 1 increased, 3 reduced, and 1 fully exited BBLG.
- Where does this BBLG ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.